相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Radioembolization with yttrium-90 resin microspheres for neuroendocrine tumor liver metastases
Ahmet Peker et al.
DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY (2015)
Radioembolization with yttrium-90 resin microspheres for neuroendocrine tumor liver metastases
Ahmet Peker et al.
DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY (2015)
Evaluation of 68Ga-DOTANOC PET/CT imaging in a large exclusive population of pancreatic neuroendocrine tumors
Punit Sharma et al.
ABDOMINAL IMAGING (2015)
18F-FDG PET-derived parameters as prognostic indices in hepatic malignancies after 90Y radioembolization: is there a role?
Oreste Bagni et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
SUV of [68Ga]DOTATOC-PET/CT Predicts Response Probability of PRRT in Neuroendocrine Tumors
C. Kratochwil et al.
MOLECULAR IMAGING AND BIOLOGY (2015)
Recommendations for management of patients with neuroendocrine liver metastases
Andrea Frilling et al.
LANCET ONCOLOGY (2014)
The Role of 18F-FDG-PET and PET/CT in Patients with Colorectal Liver Metastases Undergoing Selective Internal Radiation Therapy with Yttrium-90: A First Evidence-Based Review
Salvatore Annunziata et al.
SCIENTIFIC WORLD JOURNAL (2014)
SUVmax of 2.5 should not be embraced as a magic threshold for separating benign from malignant lesions
Thomas C. Kwee et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Radioembolisation with 90Y-labelled resin microspheres in the treatment of liver metastasis from breast cancer
R. Cianni et al.
EUROPEAN RADIOLOGY (2013)
68Ga-labelled peptides for diagnosis of gastroenteropancreatic NET
Valentina Ambrosini et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Comparison of 68Ga-DOTATATE and 68Ga-DOTANOC PET/CT imaging in the same patient group with neuroendocrine tumours
Levent Kabasakal et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
High management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours
Michael S. Hofman et al.
JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY (2012)
90Y Radioembolization After Radiation Exposure from Peptide Receptor Radionuclide Therapy
Samer Ezziddin et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
90Y-PET for the assessment of microsphere biodistribution after selective internal radiotherapy
Oreste Bagni et al.
NUCLEAR MEDICINE COMMUNICATIONS (2012)
Predictors of response to radio-embolization (TheraSphere (R)) treatment of neuroendocrine liver metastasis
Mohammed Shaheen et al.
HPB (2012)
A Multimodal Approach to the Management of Neuroendocrine Tumour Liver Metastases
Ron Basuroy et al.
INTERNATIONAL JOURNAL OF HEPATOLOGY (2012)
Selective Internal Radiation Therapy for Gastrointestinal Neuroendocrine Tumour Liver Metastases: A New and Effective Modality for Treatment
Harshal Rajekar et al.
INTERNATIONAL JOURNAL OF HEPATOLOGY (2011)
68Ga-DOTATATE PET/CT for the Early Prediction of Response to Somatostatin Receptor-Mediated Radionuclide Therapy in Patients with Well-Differentiated Neuroendocrine Tumors
Alexander R. Haug et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
68Ga-DOTA-Tyr3-Octreotide PET for Assessing Response to Somatostatin-Receptor-Mediated Radionuclide Therapy
Michael Gabriel et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Peptide-receptor radionuclide therapy for endocrine tumors
Martijn van Essen et al.
NATURE REVIEWS ENDOCRINOLOGY (2009)
Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres:: Early results in 148 patients
Andrew S. Kennedy et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2008)
Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases
Julie King et al.
CANCER (2008)
Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours
Valentina Ambrosini et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?
P. Antunes et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: A consensus panel report from the Radioembolization Brachytherapy Oncology Consortium
Andrew Kennedy et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Limitations with the response evaluation criteria in solid tumors (RECIST) guidance in disseminated pediatric malignancy
AM Barnacle et al.
PEDIATRIC BLOOD & CANCER (2006)
Large-volume liver metastases from neuroendocrine tumors:: Hepatic intraarterial 90Y-DOTA-lanreotide as effective palliative therapy
MKG McStay et al.
RADIOLOGY (2005)
Chemoembolization and other ablative therapies for liver metastases of gastrointestinal endocrine tumours
D O'Toole et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2005)
Metastatic carcinoid tumors: A clinical review
JM Zuetenhorst et al.
ONCOLOGIST (2005)
Fluorodeoxyglucose positron emission tomography and somatostatin receptor scintigraphy for diagnosing and staging carcinoid tumours: correlations with the pathological indexes p53 and Ki-67
T Belhocine et al.
NUCLEAR MEDICINE COMMUNICATIONS (2002)
分享论文
